Is Sugar Defender Fda Approved

The U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have recently issued warning letters to 10 companies for illegally selling dietary supplements that claim to cure, treat, mitigate, or prevent diabetes. These companies are in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The FDA strongly advises consumers not to use these products or similar ones, as they have not been evaluated by the FDA for safety or effectiveness and may pose potential harm.

The companies issued warning letters include Live Good Inc., Pharmaganics LLC, Lysulin Inc., Nuturna International LLC, Phytag Labs, Ar-Rahman Pharm LLC, Metamune Inc., Holistic Healer & Wellness Center Inc., Radhanite LLC, and Aceva LLC.

According to Cara Welch, Ph.D., Acting Director of the Office of Dietary Supplement Programs in the FDA’s Center for Food Safety and Applied Nutrition, “More than 34 million Americans— just over 1 in 10 people— are living with diabetes. Dietary supplements that make fraudulent claims to treat diabetes are unapproved new drugs that could potentially harm consumers who use these products instead of seeking safe and effective FDA-approved treatments.”

Under the FD&C Act, products intended to diagnose, cure, treat, mitigate, or prevent diseases are considered drugs and are subject to the same requirements as drugs, even if they are marketed as dietary supplements. Unlike FDA-approved drugs, the unapproved products mentioned in the warning letters have not been evaluated for safety, proper dosage, potential interactions, or possible side effects.

The FDA strongly recommends that consumers consult their healthcare providers before purchasing or using any dietary supplement or drug. It is essential to seek reliable and scientifically proven treatments for diabetes rather than relying on unproven and potentially unsafe supplements.

If consumers suspect that a product has caused a reaction or illness, they should discontinue its use immediately and contact their healthcare provider. The FDA also encourages healthcare providers and consumers to report any adverse reactions associated with FDA-regulated products through MedWatch or the Safety Reporting Portal.

The FDA has requested responses from the companies mentioned in the warning letters within 15 working days, asking them to address the issues or provide supporting information to justify why they believe their products are not in violation of the law. Failure to comply may result in legal action, including product seizure and injunction.

In conclusion, it is crucial for consumers to be cautious when purchasing and using dietary supplements or drugs. Always consult with a healthcare professional and rely on FDA-approved treatments for diabetes. The FDA remains committed to protecting consumers from products and companies that make unlawful claims and will continue to inform the public about potentially dangerous products.